"Cardiotoxicity" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Damage to the heart or its function secondary to exposure to toxic substances such as drugs used in CHEMOTHERAPY; IMMUNOTHERAPY; or RADIATION.
| Descriptor ID |
D066126
|
| MeSH Number(s) |
C23.550.161 C25.100.389 C26.733.266 G01.750.748.500.266
|
| Concept/Terms |
Cardiotoxicity- Cardiotoxicity
- Cardiotoxicities
- Cardiac Toxicity
- Cardiac Toxicities
- Toxicities, Cardiac
- Toxicity, Cardiac
|
Below are MeSH descriptors whose meaning is more general than "Cardiotoxicity".
Below are MeSH descriptors whose meaning is more specific than "Cardiotoxicity".
This graph shows the total number of publications written about "Cardiotoxicity" by people in this website by year, and whether "Cardiotoxicity" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2016 | 2 | 1 | 3 |
| 2017 | 14 | 15 | 29 |
| 2018 | 16 | 23 | 39 |
| 2019 | 1 | 9 | 10 |
| 2020 | 4 | 5 | 9 |
| 2021 | 2 | 1 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Cardiotoxicity" by people in Profiles.
-
Hydroxychloroquine: a comprehensive review and its controversial role in coronavirus disease 2019. Ann Med. 2021 12; 53(1):117-134.
-
Comprehensive Cardiotoxicity Assessment of COVID-19 Treatments Using Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes. Toxicol Sci. 2021 08 30; 183(1):227-239.
-
Cardiovascular Care of the Oncology Patient During COVID-19: An Expert Consensus Document From the ACC Cardio-Oncology and Imaging Councils. J Natl Cancer Inst. 2021 05 04; 113(5):513-522.
-
Mechanisms of Cardiovascular Toxicities Associated With Immunotherapies. Circ Res. 2021 05 28; 128(11):1780-1801.
-
Cardiotoxicity of Immune Checkpoint Inhibitors. Curr Oncol Rep. 2021 05 03; 23(7):79.
-
In vitro safety "clinical trial" of the cardiac liability of drug polytherapy. Clin Transl Sci. 2021 05; 14(3):1155-1165.
-
Cardiovascular Toxicities of Androgen Deprivation Therapy. Curr Treat Options Oncol. 2021 04 17; 22(6):47.
-
Cardiotoxic Potential of Hydroxychloroquine, Chloroquine and Azithromycin in Adult Human Primary Cardiomyocytes. Toxicol Sci. 2021 04 12; 180(2):356-368.
-
Protective effect of Rosuvastatin on Azithromycin induced cardiotoxicity in a rat model. Life Sci. 2021 Mar 15; 269:119099.
-
Hydroxychloroquine in the post-COVID-19 era: will this pandemic upset decades of clinical practice? Clin Rheumatol. 2021 Apr; 40(4):1649-1657.